Hormonal
Childhood stunting is associated with altered metabolic profiles in adulthood, including lower fasting insulin, higher insulin sensitivity, and abnormal beta cell function, which may predispose stunted individuals to obesity and insulin resistance later in life.
For parents in low-resource settings, addressing childhood stunting is crucial not just for height, but for long-term metabolic health. Stunted children may have altered insulin sensitivity and beta cell function, increasing their risk of obesity and diabetes later in life.
It was concluded that the environment in shantytowns impairs growth potential and that stunted children growing up in these environments have abnormal beta cell function and lower fasting insulin and higher insulin sensitivity.
Why this rating
Observational study with a small sample size (58 children) and specific to a shantytown environment in Brazil.
Source
Application of Stable Isotopic Techniques in the Prevention of Degenerative Diseases like Obesity and NIDDM in Developing Societies
Prakash Shetty et al. · Food and Nutrition Bulletin · 2002
DOI 10.1177/15648265020233s134
More from this paper
- Central obesity and increased total body fat are primary predictors of insulin resistance and the evolution of impaired glucose tolerance into frank diabetes, mediated by pro-inflammatory cytokines.Moderate
- Dietary fatty acid composition (specifically the n6/n3 ratio) influences fat oxidation and insulin response, with obese individuals showing higher carbohydrate oxidation and greater insulin response when consuming sunflower oil compared to canola oil.Limited
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →